CA Stock MarketDetailed Quotes

NGEN NervGen Pharma Corp

Watchlist
  • 2.540
  • +0.020+0.79%
15min DelayTrading Sep 13 10:00 ET
178.26MMarket Cap-6684P/E (TTM)

NervGen Pharma Corp Key Stats

NervGen Pharma Corp Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2021/Q40.000 / 0.000--
--2021/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2021/Q40.000 / 0.000--
--2021/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data